Abstract

Motion capture has the potential to shed light on topical drug delivery application. This approach holds promise both as a training tool, and for the development of skin technology, but first, this approach requires validation. Elongated microparticles (EMP) are a physical delivery enhancement technology that relies on a user working in the microparticles using a textured applicator. We used this approach to test the hypothesis that motion capture data can be used to characterize the topical application process. Motion capture was used to record participants while applying a mixture of EMP and sodium fluorescein to ex-vivo porcine skin samples. Treated skin was assessed using reflectance confocal and fluorescence microscopy. Image analysis was used to quantify the microparticle density and the presence of a fluorescent drug surrogate, sodium fluorescein. A strong correlation was present between applicator motion and microparticle and drug delivery profiles. There were quantitative and qualitative differences in the intra- and inter- user application methods that went beyond the level of training. Frequency and velocity of the applicator motion were key factors that correlated with EMP density. Our quantitative analysis of an experimental dermatological device supports the hypothesis that self-application may benefit from some form of digital monitoring or training with feedback. Our conclusion is that the integration of motion capture into experimental dermatological research offers an improved and quantifiable perspective that could be broadly useful with respect to topical applications, and with respect to the instruction provided to patients and clinicians.

Highlights

  • There have been several studies demonstrating variabilities in topical applications (Singh and Morris, 2011; Wiedersberg and Guy, 2014)

  • We found that Elongated microparticles (EMP) density per mm2 could provide numerical data for transdermal delivery

  • Two key parameters were quantified to determine the effectiveness of topical delivery. These were the number of EMP per mm2 and the intensity of surface NaF determined by integrating the fluorescence intensity over the application site area

Read more

Summary

Introduction

There have been several studies demonstrating variabilities in topical applications (Singh and Morris, 2011; Wiedersberg and Guy, 2014). Solasso et al. Motion Capture for Topical Delivery showed inter- and intra- individual variabilities in pharmacokinetics of a transdermal fentanyl patch in 28 cancer patients with chronic pain (Solassol et al, 2005). As early as 1964, it was shown by Schlagel and Sanborn that instruction plays a major role in achieving repeatable and consistent application (Schlagel and Sanborn, 1964), this requires knowledge of optimal delivery methods, which may be lacking in research literature. Sunscreen is one of the most common regulated topical products on the consumer market, controversy still exists about optimal application and delivery methods (Yamada et al, 2020). There is a gap in our capacity to quantify application parameters, beyond measuring the amount of a formulation present after application

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.